Episode

China Wins Fields Medal, GLP-1 Drugs Linked to Hair Loss, Nuvectis Drug Outperforms in PNH Trial, AI Reveals 3D Genome in Alzheimer, and more...

Podcast
Science News Daily
Published
Jul 27, 2026
Duration seconds
612
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/eb04fa73
Audio
https://media.transistor.fm/eb04fa73/cda0c21b.mp3
JSON
/v1/public/podcasts/science-news-daily-6698943/episodes/china-wins-fields-medal-glp-1-drugs-linked-to-hair-loss-nuvectis-drug-outperforms-in-pnh-trial-ai-reveals-3d-genome-in-alzheimer-and-more
Markdown
/podcast/science-news-daily-6698943/china-wins-fields-medal-glp-1-drugs-linked-to-hair-loss-nuvectis-drug-outperforms-in-pnh-trial-ai-reveals-3d-genome-in-alzheimer-and-more.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/science-news-daily-6698943/episodes/china-wins-fields-medal-glp-1-drugs-linked-to-hair-loss-nuvectis-drug-outperforms-in-pnh-trial-ai-reveals-3d-genome-in-alzheimer-and-more/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/science-news-daily-6698943/china-wins-fields-medal-glp-1-drugs-linked-to-hair-loss-nuvectis-drug-outperforms-in-pnh-trial-ai-reveals-3d-genome-in-alzheimer-and-more.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

(0:10): Chinese Researchers Make History with Fields Medal Win for Pioneering Work in Mathematical Physics (2:07): GLP-1 Agonists Linked to Increased Hair Loss Risk Compared to Other Diabetes Drugs (3:50): China Approves Nuvectis' Ciprocopan for PNH, Outperforming Eculizumab in Phase 3 Trial (6:00): AI and Multiomics Reveal 3D Genome Changes Driving Alzheimer's Progression (8:23): OPTIMA Trial: Prosigna Test Safely Reduces Chemotherapy in High-Risk Breast Cancer Patients To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: BigGo Finance